Latest / The National Briefing

South Africa has made global headlines by becoming the first country in Africa — and only the third in the world — to approve lenacapavir (LEN), a revolutionary twice-yearly injectable drug that prevents HIV infection
South Africa has made global headlines by becoming the first country in Africa — and only the third in the world — to approve lenacapavir (LEN), a revolutionary twice-yearly injectable drug that prevents HIV infection.
Guest: Prof. Glenda Gray - Director of the Infectious Disease and Oncology Research Institute (IDORI) at Wits University
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.